Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203437
Company: AUROBINDO PHARMA LTD

Products on ANDA 203437

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 203437

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/19/2015	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/30/2020	SUPPL-4	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 203437

ENTACAPONE

TABLET;ORAL; 200MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
COMTAN	ENTACAPONE	200MG	TABLET;ORAL	Prescription	Yes	AB	020796	ORION PHARMA
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	205792	AJANTA PHARMA LTD
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	212601	ALEMBIC
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	203437	AUROBINDO PHARMA LTD
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	207210	MACLEODS PHARMS LTD
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	090690	SUN PHARM
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	206669	SUNSHINE
ENTACAPONE	ENTACAPONE	200MG	TABLET;ORAL	Prescription	No	AB	078941	WOCKHARDT BIO AG